Enovix
ENVXNASDAQUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $2.64 Prior regular-session close from the quote source.
- $2.52–$2.78 Regular-session low and high so far today.
- 6.9M Regular-session shares traded · Nov 11, 4:00 PM ET.
- Jan 19 projected Projected for 2027-01-19 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
- $2.19–$9.19 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own ENVX if AI-1 wins OEM qualification and Fab2 turns silicon-anode performance into profitable volume before the balance sheet forces costly funding.
ENVX price history
Loading recent earnings…
Investment thesis
What must happen next
AI-1’s silicon-anode architecture solves a real battery constraint in compact AI-capable devices, so OEM qualification can convert technical performance into design wins.HoldingMateriality: High
FY2025 GAAP annual revenue rose to $31.8 million, up 38% year over year from $23.1 million in FY2024. If this holds, Enovix can move from sampling revenue to platform-level adoption; if it fails, the company remains a niche supplier with insufficient scale.
Watch: The two smartphone OEM market leaders end AI-1 qualification or select incumbent silicon-doped batteries instead.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
FY2025 GAAP annual revenue rose to $31.8 million, up 38% year over year from $23.1 million in FY2024.
Open source ↗The moat only matters if Enovix can manufacture the architecture at acceptable yield and throughput in Malaysia and South Korea, turning performance into sellable cells rather than expensive prototypes.StrengtheningMateriality: High
FY2025 GAAP annual gross profit was positive at $6.1 million versus a GAAP annual gross loss of $2.0 million in FY2024. Manufacturing execution determines whether revenue growth becomes profitable gross profit or consumes capital at scale.
Watch: Fab2 customer audits fail to progress into production approvals.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
FY2025 GAAP annual gross profit was positive at $6.1 million versus a GAAP annual gross loss of $2.0 million in.
Open source ↗Defense and industrial customers provide a commercialization bridge because they value high discharge rate, energy density, flight time and supply-chain diversification before consumer electronics reaches scale.StrengtheningMateriality: Medium
MD&A says defense shipments remained Enovix’s largest FY2025 revenue contributor. This bridge can fund learning, validate reliability, and reduce dependence on a single smartphone launch path; if it weakens, the company becomes more binary.
Watch: Defense customers shift drone, subsea, or munitions battery programs to established lithium-ion suppliers.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
MD&A says defense shipments remained Enovix’s largest FY2025 revenue contributor.
Open source ↗Enovix needs enough liquidity to reach manufacturing scale before persistent losses and capital needs transfer too much upside to new capital providers.HoldingMateriality: Medium
FY2025 cash and cash equivalents were $106.0 million at fiscal year-end. Even a valid technology can be a poor equity outcome if funding needs force dilution or debt pressure before volume production arrives.
Watch: Fab2 ramp delays require another large equity or convertible financing before customer volumes arrive.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
FY2025 cash and cash equivalents were $106.0 million at fiscal year-end.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
AI-1’s silicon-anode architecture solves a real battery constraint in compact AI-capable devices, so OEM qualification can convert technical performance into design wins. If this holds, Enovix can move from sampling revenue to platform-level adoption; if it fails, the company remains a niche supplier with insufficient scale.
The moat only matters if Enovix can manufacture the architecture at acceptable yield and throughput in Malaysia and South Korea, turning performance into sellable cells rather than expensive prototypes. Manufacturing execution determines whether revenue growth becomes profitable gross profit or consumes capital at scale.
Defense and industrial customers provide a commercialization bridge because they value high discharge rate, energy density, flight time and supply-chain diversification before consumer electronics reaches scale. This bridge can fund learning, validate reliability, and reduce dependence on a single smartphone launch path; if it weakens, the company becomes more binary.
Enovix needs enough liquidity to reach manufacturing scale before persistent losses and capital needs transfer too much upside to new capital providers. Even a valid technology can be a poor equity outcome if funding needs force dilution or debt pressure before volume production arrives.
All standing thesis claims
Original report summary
AI-1 wins OEM qualification and Fab2 turns silicon-anode performance into profitable volume before the balance sheet forces costly funding.
Bull case and bear case
Bull case and bear case for Enovix
Where the evidence on Enovix stands: Holding on the latest evidence (Oct 23, 2026). Of its 4 thesis points, 2 strengthening and 2 holding.
Bull case: what the evidence supports
AI-1’s silicon-anode architecture solves a real battery constraint in compact AI-capable devices, so OEM qualification can convert technical performance into design wins.
The moat only matters if Enovix can manufacture the architecture at acceptable yield and throughput in Malaysia and South Korea, turning performance into sellable cells rather than expensive prototypes.
Defense and industrial customers provide a commercialization bridge because they value high discharge rate, energy density, flight time and supply-chain diversification before consumer electronics reaches scale.
Enovix needs enough liquidity to reach manufacturing scale before persistent losses and capital needs transfer too much upside to new capital providers.
Bear case: what would count against it
The two smartphone OEM market leaders end AI-1 qualification or select incumbent silicon-doped batteries instead.
Fab2 customer audits fail to progress into production approvals.
Defense customers shift drone, subsea, or munitions battery programs to established lithium-ion suppliers.
Thesis-Break Engine
What has broken in Enovix’s thesis
Each break OptimistFi flagged on Enovix, dated — with what has historically followed the same kind of break across the market, not a forecast for Enovix.
- CEO / officer changecondition set before this filing
Across all companies, this kind of break has happened 16,849 times before. Those stocks trailed comparable companies by a median of 2% over the next six months, and 38% of them trailed it by 10 points or more.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedRegulation FD disclosure.
Enovix filed an SEC 8-K on 2026-10-22: Regulation FD disclosure. It is a dated development that tests the current thesis.
- MixedReported results of operations (earnings release).
Enovix filed an SEC 8-K on 2026-10-13: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
- MixedDirector or principal officer change.
Enovix filed an SEC 8-K on 2026-08-17: Director or principal officer change. It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- The two smartphone OEM market leaders end AI-1 qualification or select incumbent silicon-doped batteries instead.
- Fab2 customer audits fail to progress into production approvals.
- Defense customers shift drone, subsea, or munitions battery programs to established lithium-ion suppliers.
- Fab2 ramp delays require another large equity or convertible financing before customer volumes arrive.
ENVX news
Loading headlines…
Financial statements
ENVX income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
ENVX: quick answers
- When does Enovix (ENVX) report earnings next?
- Enovix's next results are projected for January 19, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on October 13, 2026. Earnings calendar
- What is ENVX's short interest?
- As of October 30, 2026, 50.4M ENVX shares were sold short, 23.0% of its shares outstanding, down 12.2% from the count before. At the stock's average daily volume that is 4.1 days to cover. FINRA publishes the count twice a month. ENVX short interest history
- Have members of Congress traded ENVX?
- 1 trade in ENVX has been disclosed under the STOCK Act by members of Congress, the President or senior officials, none in reports made public in the last 90 days. Every disclosed ENVX trade